Epicrispr Biotechnologies logo

Epicrispr Biotechnologies

The future of genetic medicine is epic.

48 employees · est. 2018 · South San Francisco, United...

VS
SonoThera logo

SonoThera

SonoThera is developing ultrasound-mediated nonviral genetic therapies.

54 employees · est. 2021 · South San Francisco, United...

Epicrispr Biotechnologies is the older company (2018 vs 2021); SonoThera is the larger of the two.

Side-by-Side Comparison

Epicrispr Biotechnologies SonoThera
Founded
2018 older 2021
Headquarters
South San Francisco, United States South San Francisco, United States
Employees
48 54 larger
Industry
Biotechnology Biopharma, Biotechnology
Funding Stage
Series B Series A
Total Funding
$123.00M $60.75M
Funding Rounds
4 1
Services
Development of therapies to control gene expression, Utilization of epigenomic modulators, Creating customized treatments for specific diseases Development of Ultrasound-Mediated Gene Delivery Technology, Nonviral Genetic Medicine for Targeted Delivery, Research and Development in Genetic Medicine
Target Customers
Patients with complex diseases, Caregivers, Healthcare Providers, Biotech Researchers Patients with Genetic Disorders, Pharmaceutical Companies, Biotech Research Institutions, Healthcare Providers
Taxonomy
Genetic Medicine, Gene Expression Modulation, CasMINI Technology, In Vivo Therapies, Ultracompact Therapies, CRISPR/Cas Proteins, Gene Therapy Innovations, Targeted Gene Regulation, Molecular Biology, Genetic Engineering, Therapeutic Development, Genomic Technologies Ultrasound-mediated Therapies, Nonviral Genetic Therapies, Genetic Medicine, Disease Treatment Innovation, Gene Therapy, Ultrasound Technology, Therapeutic Development, Advanced Drug Delivery, Biomedical Research, Genetic Engineering, Precision Medicine
Website
epicrispr.com sonothera.com
Epicrispr Biotechnologies logo

About Epicrispr Biotechnologies

Epicrispr Biotechnologies, founded in 2018, stands at the forefront of the biotechnology sector. With a vision aptly captured in its slogan, "The future of genetic medicine is epic," the company is pioneering ultracompact therapies that leverage the smallest known Cas protein, CasMINI, to modulate g...

SonoThera logo

About SonoThera

SonoThera is a promising player in the Biopharma and Biotechnology industries, founded in 2021 and headquartered in the United States. The company is carving a niche by developing ultrasound-mediated nonviral genetic therapies, a cutting-edge technological approach that sets it apart in the competit...

We will tell you when either one moves

BounceWatch watches Epicrispr Biotechnologies and SonoThera for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Epicrispr Biotechnolog... and SonoThera — by email.

Frequently Asked Questions

Epicrispr Biotechnologies — The future of genetic medicine is epic.. SonoThera — SonoThera is developing ultrasound-mediated nonviral genetic therapies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Epicrispr Biotechnologies has raised $123.00M while SonoThera has raised $60.75M.
Epicrispr Biotechnologies and SonoThera operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Epicrispr Biotechnologies with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Epicrispr Biotechnologies on 15 Jun 2026, and SonoThera on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy